Attached files
file | filename |
---|---|
EX-5.1 - EX-5.1 - MEDCO HEALTH SOLUTIONS INC | y86549exv5w1.htm |
EX-4.1 - EX-4.1 - MEDCO HEALTH SOLUTIONS INC | y86549exv4w1.htm |
EX-4.2 - EX-4.2 - MEDCO HEALTH SOLUTIONS INC | y86549exv4w2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 10, 2010
MEDCO HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
(State or other jurisdiction of incorporation)
1-31312 | 22-3461740 | |
(Commission File Number) | (I.R.S. Employer Identification No.) | |
100 Parsons Pond Drive, Franklin Lakes, NJ | 07417 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: 201-269-3400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 9.01 Financial Statements and Exhibits.
Medco Health Solutions, Inc. hereby files the following exhibits to, and incorporates such
exhibits by reference in, the Registration Statement which was filed on March 12, 2008 and
supplemented by the Prospectus Supplement dated on September 7, 2010, or otherwise pursuant to
requirements of Form 8-K:
4.1
|
Form of 2.750% Notes due 2015 | |
4.2
|
Form of 4.125% Notes due 2020 | |
5.1
|
Opinion of Sullivan & Cromwell LLP | |
23.1
|
Consent of Sullivan & Cromwell LLP (included in Exhibit 5.1) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDCO HEALTH SOLUTIONS, INC. |
||||
Date: September 10, 2010 | By: | /s/ Thomas M. Moriarty | ||
Thomas M. Moriarty | ||||
General Counsel, Secretary and Senior Vice President |
EXHIBIT INDEX
Exhibit No. | Description | |
4.1
|
Form of 2.750% Notes due 2015 | |
4.2
|
Form of 4.125% Notes due 2020 | |
5.1
|
Opinion of Sullivan & Cromwell LLP | |
23.1
|
Consent of Sullivan & Cromwell LLP (included in Exhibit 5.1) |